A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...

Researchers from Tokyo Metropolitan University have developed a way to treat ageing-related muscular atrophy using regenerative ...

BCDA], a developer of cellular therapies for cardiovascular diseases with a current market capitalization of $12 million, has announced the completion of enrollment and dosing for the low-dose cohort ...

NEW YORK, NY, USA I 12, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental ...

DNA hydrogels are biocompatible drug delivery systems for targeted therapeutic interventions. Conventional DNA hydrogels, formed with many DNA nanostructure units, lead to increased preparation costs ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

Prominent players in the Cardiac Tissue Engineering market include, Terumo corporation (Japan), Artivion, Inc. (US), Baxter ...

Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

Dr. Shimmura explained that this therapy offers two major benefits: it reduces inflammation and promotes healing at the same ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues.

"We are excited to collaborat with PHC to unlock new possibilities in cell culture," explained Michael May, President and CEO ...